Daniel Cohen
Senior Scientist, Lytica Therapeutics
Enrollment Year - 2013
Walensky Lab - DFCI
Advisor: Loren Walensky
Dissertation Title: Nonenzymatic Cysteine Modification Regulates Pro-Apoptotic BAX